12-117916066-A-C
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_173598.6(KSR2):c.180+52010T>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.405 in 150,918 control chromosomes in the GnomAD database, including 13,386 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.41 ( 13386 hom., cov: 29)
Consequence
KSR2
NM_173598.6 intron
NM_173598.6 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -0.563
Publications
6 publications found
Genes affected
KSR2 (HGNC:18610): (kinase suppressor of ras 2) Predicted to enable MAP-kinase scaffold activity; mitogen-activated protein kinase kinase binding activity; and protein kinase activity. Predicted to be involved in Ras protein signal transduction; calcium-mediated signaling; and positive regulation of cold-induced thermogenesis. Predicted to act upstream of or within positive regulation of MAPK cascade. Predicted to be active in cytosol and plasma membrane. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-1.01).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.683 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.405 AC: 61107AN: 150804Hom.: 13342 Cov.: 29 show subpopulations
GnomAD3 genomes
AF:
AC:
61107
AN:
150804
Hom.:
Cov.:
29
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.405 AC: 61196AN: 150918Hom.: 13386 Cov.: 29 AF XY: 0.410 AC XY: 30174AN XY: 73610 show subpopulations
GnomAD4 genome
AF:
AC:
61196
AN:
150918
Hom.:
Cov.:
29
AF XY:
AC XY:
30174
AN XY:
73610
show subpopulations
African (AFR)
AF:
AC:
21016
AN:
40892
American (AMR)
AF:
AC:
6989
AN:
15116
Ashkenazi Jewish (ASJ)
AF:
AC:
1363
AN:
3460
East Asian (EAS)
AF:
AC:
3614
AN:
5148
South Asian (SAS)
AF:
AC:
2389
AN:
4774
European-Finnish (FIN)
AF:
AC:
3211
AN:
10314
Middle Eastern (MID)
AF:
AC:
98
AN:
294
European-Non Finnish (NFE)
AF:
AC:
21300
AN:
67910
Other (OTH)
AF:
AC:
807
AN:
2100
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.490
Heterozygous variant carriers
0
1638
3277
4915
6554
8192
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
576
1152
1728
2304
2880
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2211
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.